Novo Nordisk A/S (NVO) Announces FDA Approval of Three New Indications for Sogroya

1 3 月, 2026

One Min Read

9 Views

原文: https://finance.yahoo.com/news/novo-nordisk-nvo-announces-fda-092756065.html

Last Update: 1 3 月, 2026

Written By

Other Articles

Previous

Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM

Next

Grupo Santander Downgrades BP p.l.c. (BP) to Neutral from Outperform

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept